About AllazoHealth
Optimizing quality performance, patient interventions, and
health outcomes with AI technology.
Delivering personalized patient interventions for better outcomes.
AllazoHealth is a healthcare technology company that leverages the power of artificial intelligence to optimize patient outcomes. Our AI engine targets high-risk patients who are most likely to respond to interventions.
AllazoHealth Leadership Team
Clifford has been driving the use of AI in patient engagement and outcome optimization for nearly a decade. Upon founding AllazoHealth, Clifford built an industry-leading predictive analytics engine which has won multiple awards and whose impact has been validated through multiple peer reviewed studies. Clifford led AllazoHealth through its formative years and has transitioned to the CTO role as AllazoHealth has grown.
Before founding AllazoHealth, Clifford developed CVS Health’s award-winning Pharmacy Advisor medication adherence program in collaboration with AllazoHealth’s current CEO William Grambley, which earned the “2011 Rx Benefit Innovation Award” from the Pharmacy Benefit Management Institute and a “Best Practices in Health Care Consumer Protection and Empowerment Award” from URAC. Earlier in his career, Clifford led the development of analytics software for Boston Consulting Group’s health care practice.
Clifford graduated from the University of Pennsylvania’s dual-degree Management & Technology program where he studied management, engineering and mathematics. He entered the Wharton Health Care Management MBA program, but left to start AllazoHealth.
William is passionate about helping people get the most from their medications. As CEO of AllazoHealth, he is driving the organization’s growth to improve adherence and patient support programs. William originally joined AllazoHealth as the Chief Operating Officer and as the organization expanded, moved into the CEO role.
Prior to joining AllazoHealth, he served in a variety of leadership positions at CVS Health, including time as Vice President of Strategy and Vice President of Product Management. While at CVS Health, he delivered industry-leading clinical programs, including the award-winning Pharmacy Advisor program, which drove CVS Health clients’ Medicare Star ratings to their highest levels ever.
Earlier, William served in the US Navy before getting an MBA from Northwestern University’s Kellogg Graduate School of Management; William also worked for Bain and Company and EMC before he moved to CVS Health.
Before joining AllazoHealth, Francis held several senior financial positions at information and media companies, including Questex, Information Services Group, and Dex Media. Before these operating leadership roles, Francis was a Managing Director in private equity at The Carlyle Group and a Principal in investment banking at Morgan Stanley.
Francis received a BA with dual majors in Economics and Political Science from Amherst College and an MBA in Finance from the Wharton School at the University of Pennsylvania.
Dev joined AllazoHealth to help drive healthcare innovation. As VP, Business Development, Dev leads commercial and strategic activities to drive the company’s growth.
Before joining AllazoHealth as employee #2, Dev held strategic roles at scaling digital health companies including CipherHealth & CareDox. These operating leadership roles included spearheading business development activities as well as financing initiatives such as managing a Series B round and acquiring a tech enabled services business. Earlier in his career, Dev spent several years at Booz & Company and Cognizant within their transaction services and healthcare practices.
Dr. Linda Schultz, Pharm.D., R.Ph. is a results-oriented Healthcare Pharmacy Executive who excels at leading transformational, top-notch, interdisciplinary healthcare teams to create and execute outcomes driven clinical operations and account management initiatives. Dynamic and knowledgeable in all healthcare business segments, most passionately within the complex Medicare, Duals and Medicaid markets, she is an accomplished, creative motivator and driver of innovative quality and cost of care pharmacy interventions.
Dr. Schultz is currently VP, Clinical and Customer Success at AllazoHealth, a cutting-edge, healthcare artificial intelligence company. Prior to her leadership role at Allazo, Linda founded and led RxHorizons, LLC., an international healthcare consulting group. Her expertise stems from over 25 years of experience within the Managed Care industry, with focus on leading, strategizing, developing and implementing pharmacy benefit management activities within national PBMs and health plans. Within her tenure in healthcare management, she has led clinical pharmacy oversight for Commercial, self-insured (ASO) Employer Group, Medicare, Medicaid and Duals business and has earned her reputation through championing the coordination, promotion, and execution of Clinical Intervention and Formulary Management programs that demonstrate improved quality, operational and financial performance indicators. Through the use of measurable quality and cost-effectiveness domains, Linda has led and performed the critical appraisal of pharmaceuticals and medication management programs.
Dr. Schultz was also the Vice President of Clinical Pharmacy, Government Services at Amerigroup, including centralized oversight of Medicare Pharmacy benefit management and Staff VP of Clinical Pharmacy Government Business Division at WellPoint/Anthem. She has also held leadership roles within the PBM and Health Insurance industry that focus on pharmacy account management activities. Dr. Schultz was also a Clinical Assistant Professor at the State University of New York at Buffalo School of Pharmacy where she earned her Bachelor of Science degree and won Preceptor of the Year. Linda graduated Magna Cum Laude earning her Doctor of Pharmacy degree (Pharm.D.) from Shenandoah University, Bernard J. Dunn School of Pharmacy. She is a licensed, registered pharmacist in New York and is the Past President of the Northeast Academy of Managed Care Pharmacy (AMCP) affiliation.
Bala believes that data engineering is an art of collecting and enriching the data. As Director of Data Engineering at AllazoHealth, he architects solutions that make healthcare and social data ready for machine learning.
Prior to joining AllazoHealth, he worked at Gabriels Technology Solutions (real estate) and FTI Consulting (eDiscovery). At FTI, he achieved several milestones, including leading an innovative project for integrating cloud data sources. At Gabriels, he developed and managed a data processing team, and helped set up and oversee a regional office in Chennai, India from scratch.
Improving the medication adherence of people through predictive analytics and solving data challenges excites him at AllazoHealth.
Predict high-risk patients with the greatest potential for change.
Use our AI engine to identify high-risk patients who are most likely to change their behaviors for more efficient, cost-effective interventions.
Deliver personalized engagements for each individual patient.
Ensure each patient intervention is personalized by channel, content, and timing to increase the likelihood of success and improve cost-effectiveness.
Enhance patient engagement programs to improve outcomes.
Leverage AI to deliver innovative patient support programs that result in better therapy initiation, health outcomes, and quality ratings.
